Vertically-integrated payments platform for medical aesthetic practices
An integrated financial technology (fintech) platform designed to transform both the practice and patient experience.
Learn More
Powering Prestige Experiences in Aesthetics with Products and Services Portfolio
The HintMD platform provides a seamless, simple and smart payment solution that empowers aesthetic practices to improve practice management, practice economics and practice loyalty.
Visit HintMD.comAcquisition provides Revance access to a $500M+ opportunity in U.S. aesthetic practice payment services 1
Products and Services
DaxibotulinumtoxinA for Injection is an investigational agent that has not been approved by the FDA and is currently under regulatory review.
Powering Prestige Practice and Patient Experiences
Patient subscriptions and practice loyalty programs improve practice economics
Advances Revance Aesthetics’ vision to improve outcomes for patients and practices
HintMD’s Integrated Platform
Transforms Revance Aesthetics Commercial Footprint
Leverages commercial infrastructure
Adds experienced fintech talent to:
• Expand our digital capabilities
• Address practice and patient desires for a loyalty program
• Add features and capabilities to the platform over time
Creates near-term value with recurring revenue
Aligns with Revance Aesthetics’ vision to build a prestige aesthetics category that transforms patients and practice experiences
Daring to make a difference with products and services to deliver meaningful outcomes to our customers
References
-
Data on File, IBIS, ISAPS, AmSpa
-
RHA® is a trademark of TEOXANE SA.